Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,987.60
(
0.16%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
103.79
(
3.09%
)
Bitcoin
68,227.82
(
-0.81%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: oc631 post# 163979

Friday, 07/12/2013 6:22:13 PM

Friday, July 12, 2013 6:22:13 PM

Post# of 257295

The idea of bringing a questionable oral combo to market, without an interferon-based option (which can only be superior in efficacy), makes no sense.





In hindsight GILD is trying to do this in the U.S. with Sofo/Riba in GT3. Why not Russia?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today